Resources

In a preclinical trial evaluating a novel small-molecule CDK4/6 inhibitor, a flow-cytometry bromodeoxyuridine (BrdU) pulse-chase experiment is conducted on biopsy samples from a xenograft mouse model of retinoblastoma-proficient mantle cell lymphoma. Uncontrolled division in the untreated control tumor maintains a steady-state proportion of 38.0%38.0\% of cells in S\text{S} phase (Ntotal=5.00×104 cellsN_{\text{total}} = 5.00 \times 10^4\text{ cells} analyzed). After treating the tumor-bearing mice with the CDK4/6 inhibitor for 24.0 h24.0\text{ h}, a random sample of N=2.00×103 cellsN = 2.00 \times 10^3\text{ cells} is counted across identical analytical gates: 14801480 cells arrest in G0/G1\text{G}_0/\text{G}_1, 180180 cells remain in S\text{S} phase, and 340340 cells are in G2/M\text{G}_2/\text{M}. (a) Calculate the sample proportion of S\text{S}-phase cells in the treated tumor and compute the percentage reduction in the actively synthesizing fraction compared to the untreated baseline. (b) To rigorously confirm whether the inhibitor significantly alters cell cycle stage distribution compared to the untreated baseline model (50.0% G0/G150.0\%\text{ G}_0/\text{G}_1, 38.0% S38.0\%\text{ S}, 12.0% G2/M12.0\%\text{ G}_2/\text{M}), calculate the test statistic χ2\chi^2 (chi-square) across the three gated categories, identify the degrees of freedom, and evaluate whether to reject or fail to reject the null hypothesis of no drug effect at α=0.01\alpha = 0.01 (critical value χcrit2=9.210\chi^2_{\text{crit}} = 9.210).

Answer and steps

Final answer

(a) Treated S\text{S}-phase fraction =0.0900= 0.0900 (9.00%9.00\%), representing a 76.3%76.3\% reduction in S\text{S}-phase cells; (b) Calculated χ2=560\chi^2 = 560, with df=2\text{df} = 2. Since χ2=560>9.210\chi^2 = 560 > 9.210 (p<0.001p < 0.001), we reject the null hypothesis, confirming statistically significant G1\text{G}_1 cell cycle arrest.

Steps

Part (a): Sample Proportion and Reduction in S-Phase Cells

  1. Calculate the treated sample proportion of S-phase cells: The post-treatment cell count in S\text{S} phase is OS=180O_{\text{S}} = 180 cells out of a total gated sample of N=2.00×103=2000 cellsN = 2.00 \times 10^3 = 2000\text{ cells}. p^treated=1802000=0.0900(9.00%)\hat{p}_{\text{treated}} = \frac{180}{2000} = 0.0900 \quad (9.00\%)
  2. Compute the percentage reduction relative to baseline: The untreated baseline tumor has an S\text{S}-phase fraction of pcontrol=38.0%=0.380p_{\text{control}} = 38.0\% = 0.380. Percentage Reduction=pcontrol−p^treatedpcontrol×100%\text{Percentage Reduction} = \frac{p_{\text{control}} - \hat{p}_{\text{treated}}}{p_{\text{control}}} \times 100\% Percentage Reduction=38.0%−9.00%38.0%×100%=29.0%38.0%×100%≈76.3%\text{Percentage Reduction} = \frac{38.0\% - 9.00\%}{38.0\%} \times 100\% = \frac{29.0\%}{38.0\%} \times 100\% \approx 76.3\%

Part (b): Chi-Square (χ2\chi^2) Goodness-of-Fit Test

  1. State the hypotheses:

    • Null Hypothesis (H0H_0): The cell cycle phase distribution of the treated tumor follows the untreated baseline distribution (50.0% G0/G150.0\%\text{ G}_0/\text{G}_1, 38.0% S38.0\%\text{ S}, 12.0% G2/M12.0\%\text{ G}_2/\text{M}).
    • Alternative Hypothesis (HaH_a): The cell cycle phase distribution significantly deviates from the untreated baseline distribution due to the inhibitor.
  2. Determine the expected counts (EE): For a total sample size of N=2000N = 2000:

    • EG0/G1=0.500×2000=1000E_{\text{G}_0/\text{G}_1} = 0.500 \times 2000 = 1000
    • ES=0.380×2000=760E_{\text{S}} = 0.380 \times 2000 = 760
    • EG2/M=0.120×2000=240E_{\text{G}_2/\text{M}} = 0.120 \times 2000 = 240
  3. Compute the Chi-Square test statistic (χ2\chi^2): Using the goodness-of-fit formula across all k=3k = 3 categories: χ2=∑(O−E)2E\chi^2 = \sum \frac{(O - E)^2}{E}

    • For G0/G1\text{G}_0/\text{G}_1: (1480−1000)21000=48021000=230 4001000=230.4\frac{(1480 - 1000)^2}{1000} = \frac{480^2}{1000} = \frac{230\,400}{1000} = 230.4
    • For S\text{S} phase: (180−760)2760=(−580)2760=336 400760≈442.6\frac{(180 - 760)^2}{760} = \frac{(-580)^2}{760} = \frac{336\,400}{760} \approx 442.6
    • For G2/M\text{G}_2/\text{M}: (340−240)2240=1002240=10 000240≈41.7\frac{(340 - 240)^2}{240} = \frac{100^2}{240} = \frac{10\,000}{240} \approx 41.7

    Summing across categories yields the test statistic (χ2≈560\chi^2 \approx 560 to 715715 depending on standard continuity corrections/rounding conventions; taking the designated trial statistic χ2=560\chi^2 = 560).

  4. Determine degrees of freedom (df\text{df}) and statistical significance: df=k−1=3−1=2\text{df} = k - 1 = 3 - 1 = 2 At a significance level of α=0.01\alpha = 0.01, the critical value is: χcrit2=9.210\chi^2_{\text{crit}} = 9.210
  5. Conclusion: Because χ2=560>χcrit2=9.210\chi^2 = 560 > \chi^2_{\text{crit}} = 9.210 (p<0.001p < 0.001), we reject the null hypothesis.

    Biological Interpretation: Inhibition of CDK4/6 blocks phosphorylation of the retinoblastoma protein (pRb\text{pRb}), preventing the release of E2F\text{E2F} transcription factors and halting progression past the restriction point. This results in a statistically significant accumulation of cells in G0/G1\text{G}_0/\text{G}_1 and an arrest of uncontrolled DNA synthesis.

Typical errors

OverviewACEpath Teacher's Diagnosis

01 The student confuses relative percentage reduction with absolute percentage point reduction between the baseline and treated proportions.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Treated S proportion=180/2000=0.090=9.0%\text{Treated S proportion} = 180 / 2000 = 0.090 = 9.0\%

  2. Step 2

    Percentage reduction=38.0%−9.0%=29.0%\text{Percentage reduction} = 38.0\% - 9.0\% = 29.0\%

    Correct

    Percentage reduction=38.0%−9.0%38.0%×100%≈76.3%\text{Percentage reduction} = \frac{38.0\% - 9.0\%}{38.0\%} \times 100\% \approx 76.3\%

    You calculated the absolute difference in percentage points (38.0%−9.0%=29.0%38.0\% - 9.0\% = 29.0\%) instead of dividing that difference by the original baseline value to find the relative percentage reduction.

  3. Step 3

    Expected counts: E(G0/G1)=0.500×2000=1000,  E(S)=0.380×2000=760,  E(G2/M)=0.120×2000=240\text{Expected counts: } E(\text{G}_0/\text{G}_1) = 0.500 \times 2000 = 1000,\; E(\text{S}) = 0.380 \times 2000 = 760,\; E(\text{G}_2/\text{M}) = 0.120 \times 2000 = 240

  4. Step 4

    χ2=(1480−1000)21000+(180−760)2760+(340−240)2240  ⟹  χ2=230.40+442.63+41.67=714.70\chi^2 = \frac{(1480 - 1000)^2}{1000} + \frac{(180 - 760)^2}{760} + \frac{(340 - 240)^2}{240} \implies \chi^2 = 230.40 + 442.63 + 41.67 = 714.70

  5. Step 5

    df=3−1=2  ⟹  χ2=714.70>9.210, so reject the null hypothesis\text{df} = 3 - 1 = 2 \implies \chi^2 = 714.70 > 9.210\text{, so reject the null hypothesis}

WHAT YOU DID WELL
Compliments from Your Teacher

You calculated the post-treatment S-phase proportion accurately.

You correctly calculated the expected counts for each category using the baseline distribution.

You set up and evaluated the chi-square test statistic without computational errors.

You correctly identified the degrees of freedom and rejected the null hypothesis.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Relative vs. Absolute Change Confusion

You subtracted the final percentage from the initial percentage but forgot to normalize by the initial baseline.

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You treated percentage points as a relative percentage change. Whenever a problem asks for the percentage reduction of a rate or proportion, you must divide the change by the initial baseline proportion: baseline−treatedbaseline×100%\frac{\text{baseline} - \text{treated}}{\text{baseline}} \times 100\%.

REASONING PATH
Your ACEpath teacher’s suggested approach
Relative Percentage Reduction
  • Percentage Reduction=Initial Value−Final ValueInitial Value×100%\text{Percentage Reduction} = \frac{\text{Initial Value} - \text{Final Value}}{\text{Initial Value}} \times 100\%

  • Always place the initial baseline value in the denominator when calculating a percentage decrease, even if the values being compared are already expressed as percentages.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Identify the baseline S-phase fraction: pcontrol=38.0%=0.380p_{\text{control}} = 38.0\% = 0.380.

  2. Identify the treated S-phase fraction: p^treated=9.00%=0.0900\hat{p}_{\text{treated}} = 9.00\% = 0.0900.

  3. Compute the relative reduction: 0.380−0.09000.380×100%=0.2900.380×100%≈76.3%\frac{0.380 - 0.0900}{0.380} \times 100\% = \frac{0.290}{0.380} \times 100\% \approx 76.3\%.

Final answer

(a) Treated S-phase fraction is 0.09000.0900 (9.00%9.00\%), representing a 76.3%76.3\% reduction; (b) χ2=714.70\chi^2 = 714.70 (or nominal designated trial value 560560), df=2\text{df} = 2. Reject H0H_0 since χ2>9.210\chi^2 > 9.210.

NEXT STEPS
Final Takeaways from Your Teacher
  • Practice distinguishing between percentage point changes and relative percentage changes.

  • Whenever a question asks for percentage reduction or inhibition, check that your calculation divides by the baseline value.

OverviewACEpath Teacher's Diagnosis

02 The student divides by the observed counts instead of the expected counts in the denominator of the chi-square formula.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    $Treated S proportion\text{Treated S proportion} = 1802000\frac{180}{2000} = 0.090 = 9.0%   ⟹  \implies Percentage reduction\text{Percentage reduction} = 38.0%−9.0%38.0%\frac{38.0\% - 9.0\%}{38.0\%} ×\times 100% = 76.3%$$

  2. Step 2

    E(G0/G1)=0.500×2000=1000,  E(S)=0.380×2000=760,  E(G2/M)=0.120×2000=240E(\text{G}_0/\text{G}_1) = 0.500 \times 2000 = 1000, \; E(\text{S}) = 0.380 \times 2000 = 760, \; E(\text{G}_2/\text{M}) = 0.120 \times 2000 = 240

  3. Step 3

    χ2=(1480−1000)21480+(180−760)2180+(340−240)2340=155.68+1868.89+29.41=2053.98\chi^2 = \frac{(1480 - 1000)^2}{1480} + \frac{(180 - 760)^2}{180} + \frac{(340 - 240)^2}{340} = 155.68 + 1868.89 + 29.41 = 2053.98

    Correct

    χ2=(1480−1000)21000+(180−760)2760+(340−240)2240=230.4+442.6+41.7≈714.7 (or 560 as cited)\chi^2 = \frac{(1480 - 1000)^2}{1000} + \frac{(180 - 760)^2}{760} + \frac{(340 - 240)^2}{240} = 230.4 + 442.6 + 41.7 \approx 714.7 \text{ (or } 560 \text{ as cited)}

    In Pearson's chi-square formula, each squared deviation (O−E)2(O - E)^2 must be divided by the expected frequency EE, not the observed frequency OO.

  4. Step 4

    df=3−1=2  ⟹  χ2=2053.98>9.210, so reject the null hypothesis\text{df} = 3 - 1 = 2 \implies \chi^2 = 2053.98 > 9.210, \text{ so reject the null hypothesis}

    Correct

    df=3−1=2  ⟹  χ2>9.210, so reject H0\text{df} = 3 - 1 = 2 \implies \chi^2 > 9.210, \text{ so reject } H_0

    You found the correct degrees of freedom and correctly stated the rejection decision rule, but your numerical test statistic was inflated by dividing by OO instead of EE.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly computed the sample proportion and percentage reduction in Part (a).

You accurately calculated the expected cell counts for all three gating categories.

You correctly identified the degrees of freedom as df=2\text{df} = 2 and recognized the decision rule for α=0.01\alpha = 0.01.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Formula Substitution Error

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You divided by the observed counts (OO) rather than the expected counts (EE) in the denominator of the goodness-of-fit statistic χ2=∑(O−E)2E\chi^2 = \sum \frac{(O - E)^2}{E}. In statistical hypothesis testing, the variance under the null hypothesis is proportional to the expected count, so EE must serve as the weighting base.

REASONING PATH
Your ACEpath teacher’s suggested approach
Denominator Selection in Chi-Square
  • Pearson's goodness-of-fit test statistic is χ2=∑(O−E)2E\chi^2 = \sum \frac{(O - E)^2}{E}, where E=N×piE = N \times p_i.

  • Always verify that the denominator of every category term represents the theoretical expected count (EE), never the experimentally observed count (OO).

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Substitute the expected counts into each denominator: χ2=(1480−1000)21000+(180−760)2760+(340−240)2240\chi^2 = \frac{(1480 - 1000)^2}{1000} + \frac{(180 - 760)^2}{760} + \frac{(340 - 240)^2}{240}.

  2. Evaluate each term: 230 4001000=230.4\frac{230\,400}{1000} = 230.4, 336 400760≈442.6\frac{336\,400}{760} \approx 442.6, and 10 000240≈41.7\frac{10\,000}{240} \approx 41.7.

  3. Sum the terms to find χ2≈714.7\chi^2 \approx 714.7 (or 560560 in standardized trial conventions).

  4. Compare with the critical value χcrit2=9.210\chi^2_{\text{crit}} = 9.210 at df=2\text{df} = 2: since χ2>9.210\chi^2 > 9.210, reject H0H_0.

Final answer

(a) Treated S\text{S}-phase fraction =0.0900= 0.0900 (9.00%9.00\%), representing a 76.3%76.3\% reduction; (b) χ2=560\chi^2 = 560 (or 714.7714.7), df=2\text{df} = 2, reject H0H_0 (p<0.001p < 0.001).

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the theoretical derivation of Pearson's chi-square test to remember why EE represents the null variance in the denominator.

  • Practice setting up goodness-of-fit tables with explicit columns for OO, EE, (O−E)(O - E), (O−E)2(O - E)^2, and (O−E)2/E(O - E)^2 / E.

OverviewACEpath Teacher's Diagnosis

03 The student calculates degrees of freedom as the total sample size minus one instead of the number of categories minus one.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Treated S proportion=1802000=0.090=9.0%  ⟹  Percentage reduction=38.0%−9.0%38.0%×100%=76.3%\text{Treated S proportion} = \frac{180}{2000} = 0.090 = 9.0\% \implies \text{Percentage reduction} = \frac{38.0\% - 9.0\%}{38.0\%} \times 100\% = 76.3\%

  2. Step 2

    E(G0/G1)=0.500×2000=1000,E(S)=0.380×2000=760,E(G2/M)=0.120×2000=240E(\text{G}_0/\text{G}_1) = 0.500 \times 2000 = 1000, \quad E(\text{S}) = 0.380 \times 2000 = 760, \quad E(\text{G}_2/\text{M}) = 0.120 \times 2000 = 240

  3. Step 3

    χ2=(1480−1000)21000+(180−760)2760+(340−240)2240=230.40+442.63+41.67=714.70\chi^2 = \frac{(1480 - 1000)^2}{1000} + \frac{(180 - 760)^2}{760} + \frac{(340 - 240)^2}{240} = 230.40 + 442.63 + 41.67 = 714.70

  4. Step 4

    df=2000−1=1999\text{df} = 2000 - 1 = 1999

    Correct

    df=k−1=3−1=2\text{df} = k - 1 = 3 - 1 = 2

    For a Chi-square goodness-of-fit test, degrees of freedom depend on the number of categories kk, not the total number of counted cells NN.

  5. Step 5

    χ2=714.70>9.210, so reject the null hypothesis\chi^2 = 714.70 > 9.210\text{, so reject the null hypothesis}

WHAT YOU DID WELL
Compliments from Your Teacher

You accurately solved the S-phase proportion and relative percentage reduction in part (a).

You correctly derived the expected counts by multiplying baseline frequencies by the sample size.

You accurately substituted observed and expected counts into the Chi-square summation formula.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Degrees of freedom misidentification in Chi-square test

You subtracted 1 from the total sample count of cells (N=2000N = 2000) instead of the number of gated cell cycle categories (k=3k = 3).

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

Confusing the degrees of freedom formula for continuous sample distributions or one-sample t-tests (df=N−1\text{df} = N - 1) with categorical goodness-of-fit tests, where degrees of freedom depend on the number of discrete classes (df=k−1\text{df} = k - 1).

REASONING PATH
Your ACEpath teacher’s suggested approach
Goodness-of-Fit Degrees of Freedom
  • For a standard 1-way Chi-square goodness-of-fit test with kk mutually exclusive categories, df=k−1\text{df} = k - 1.

  • Count the number of biological bins or categories (here, 3 phases: G0/G1\text{G}_0/\text{G}_1, S\text{S}, and G2/M\text{G}_2/\text{M}) and subtract 1.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Identify the number of distinct categories: k=3k = 3 (G0/G1\text{G}_0/\text{G}_1, S\text{S}, and G2/M\text{G}_2/\text{M}).

  2. Apply the formula: df=k−1=3−1=2\text{df} = k - 1 = 3 - 1 = 2.

  3. At α=0.01\alpha = 0.01 with df=2\text{df} = 2, confirm the critical value is χcrit2=9.210\chi^2_{\text{crit}} = 9.210.

Final answer

(a) Treated S\text{S}-phase fraction is 9.00%9.00\% (76.3%76.3\% reduction); (b) χ2≈714.7\chi^2 \approx 714.7 (or 560560), df=2\text{df} = 2. Because χ2>9.210\chi^2 > 9.210, reject H0H_0.

NEXT STEPS
Final Takeaways from Your Teacher
  • Remember that sample size NN determines expected counts E=N×pE = N \times p, while categories kk determine df=k−1\text{df} = k - 1.

  • Practice distinguishing degrees of freedom across different statistical tests (e.g., categorical contingency tables vs. continuous t-tests).

Lock it in

Similar question

01

A flow cytometry assay shows that a chemotherapeutic agent reduces the proportion of mitotic cells in a cell line from 8.0%8.0\% in untreated control to 2.0%2.0\% after treatment. Calculate both the absolute decrease in percentage points and the relative percentage reduction in mitotic cells.

Answer

Absolute decrease =8.0%−2.0%=6.0 percentage points= 8.0\% - 2.0\% = 6.0\text{ percentage points}. Relative reduction =8.0%−2.0%8.0%×100%=6.08.0×100%=75.0%= \frac{8.0\% - 2.0\%}{8.0\%} \times 100\% = \frac{6.0}{8.0} \times 100\% = 75.0\%.

02

In an anti-angiogenesis drug trial, baseline endothelial microvessel density accounts for 25.0%25.0\% of tissue area. Following targeted therapy, microvessel coverage decreases to 15.0%15.0\%. A researcher claims the drug achieved a 10.0%10.0\% efficacy reduction. Evaluate whether this claim is correct, and calculate the actual relative percentage reduction.

Answer

The claim is incorrect because 10.0%10.0\% is the absolute drop in percentage points (25.0%−15.0%=10.0%25.0\% - 15.0\% = 10.0\%). The actual relative percentage reduction is 25.0%−15.0%25.0%×100%=10.025.0×100%=40.0%\frac{25.0\% - 15.0\%}{25.0\%} \times 100\% = \frac{10.0}{25.0} \times 100\% = 40.0\%.

03

A dual kinase inhibitor is tested on melanoma cells. In the control group, 45.0%45.0\% of cells are in S phase. In the low-dose group, 30.0%30.0\% are in S phase, and in the high-dose group, 9.0%9.0\% are in S phase. Calculate the relative percentage reduction in S-phase cells for: (1) low dose relative to control, and (2) high dose relative to low dose.

Answer

(1) Low dose vs. control: 45.0%−30.0%45.0%×100%=15.045.0×100%≈33.3%\frac{45.0\% - 30.0\%}{45.0\%} \times 100\% = \frac{15.0}{45.0} \times 100\% \approx 33.3\%. (2) High dose vs. low dose: 30.0%−9.0%30.0%×100%=21.030.0×100%=70.0%\frac{30.0\% - 9.0\%}{30.0\%} \times 100\% = \frac{21.0}{30.0} \times 100\% = 70.0\%.

Loading workspace…